|Articles|June 1, 2002

Protection Across the Cardiovascular Continuum: What Can Be Done for Patients at Risk?
Volume 8
Issue 9 Suppl

Call to Action

Author(s)Peter F. Cohn, MD

Download PDF: Call to Action

Articles in this issue

about 24 years ago

Article

Introduction

about 24 years ago

Article

Cardioprotection: What Is It? Who Needs It?

about 24 years ago

Article

Beta Blockers as Cardioprotective Agents: Part I -- Insights into Mechanisms of Action

about 24 years ago

Article

Beta Blockers as Cardioprotective Agents: Part II -- Focus on Prevention of Sudden Cardiac Death

about 24 years ago

Article

Statins as Cardioprotective Agents

about 24 years ago

Article

ACE Inhibitors as Cardioprotective Agents

about 24 years ago

Article

Role of Antiplatelet Agents in Cardioprotection

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

Call to Action

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

US Employer Health Care Costs Projected to Rise 9.5% in 2027

5 Things to Know About the FDA's Peptide Reversal

Student Mental Health, Success Tied to Future Health and Affordability

Rural Patients Face Gaps in Hospice Access, Care Intensity

FDA Approves First Orexin Agonist for Narcolepsy Type 1